← Back to home
Comparison · Analytics

forecasting vs medsim

A side-by-side editorial comparison of forecasting and medsim — release velocity, themes, recent moves, and the top alternatives to consider.

Shared themes:reproducibilityr package

forecasting vs medsim: at a glance

Featureforecastingmedsim
SectorAnalyticsAnalytics
Velocity score0.06.3
Sparks · 30d01
Top themesforecasting, epidemiology, reproducibility, vignettesmediation analysis, monte carlo, reproducibility, hpc
Last editorial update44m ago48m ago
WebsiteVisit →Visit →

What is forecasting?

HIDDA.forecasting is a book chapter's reproducibility artifact, not a package under development.

HIDDA.forecasting accompanies a book chapter on forecasting infectious disease counts; its vignettes reproduce the results presented there using arima, prophet, glarma, hhh4contacts and scoringRules. The 1.0.0 release states this outright — it is the version used for the chapter, pinned to CRAN package versions as of July 2018. Every release since has been a vignette rebuild against newer R and dependency versions.

Read the full forecasting trajectory →

What is medsim?

medsim is turning simulation runs into auditable artifacts, not just fast ones.

medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.

Read the full medsim trajectory →

forecasting vs medsim: editorial side-by-side

F
forecasting
ANALYTICS
0.0

HIDDA.forecasting is a book chapter's reproducibility artifact, not a package under development.

◆ Current state

HIDDA.forecasting accompanies a book chapter on forecasting infectious disease counts; its vignettes reproduce the results presented there using arima, prophet, glarma, hhh4contacts and scoringRules. The 1.0.0 release states this outright — it is the version used for the chapter, pinned to CRAN package versions as of July 2018. Every release since has been a vignette rebuild against newer R and dependency versions.

◆ Where it's heading

The release pattern is maintenance on an eight-year cadence dictated entirely by the surrounding ecosystem: 1.1.1 rebuilt under R 4.0.4, 1.1.2 under R 4.3.2, 1.1.3 under R 4.6.1, each reporting whether the numbers moved. They mostly have not — the recurring note is minor numerical differences confined to the prophet forecasts in vignette('CHILI_prophet'). The only substantive change in the visible history is 1.1.0's methodological tidy-up of the scoring comparisons.

◆ Prediction

Nothing in these entries points to new functionality; the next release is most likely another vignette rebuild whenever a dependency change or a CRAN check failure forces one.

M
medsim
ANALYTICS
6.3

medsim is turning simulation runs into auditable artifacts, not just fast ones.

◆ Current state

medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.

◆ Where it's heading

The arc is toward defensible HPC runs: each 0.5.x gate closes a way a cluster job could silently produce wrong output, and 0.5.1 extends the same suspicion to the estimator itself by exposing the branch disagreement the standard ARIV averages away. Releases are cadenced against discovered defects rather than a roadmap — 0.5.0 cites seven findings from a pre-integration review, and 0.5.1 cites an adversarial review of 0.5.0. The audit surface is widening faster than the method surface.

◆ Prediction

The collapse-audit exclusion list has now been patched twice for method-specific diagnostic columns, so the next likely move is a contract letting methods declare their own discrete fields instead of medsim naming them centrally.

Alternatives to forecasting and medsim

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either forecasting or medsim.

See all forecasting alternatives → · See all medsim alternatives →

Recent activity from forecasting and medsim

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 7h agomedsimmedsim 0.5.1 — fixed-branch ARIV
  2. 16d agomedsimmedsim 0.5.0 — chunked-run integrity
  3. 1mo agoforecastingVignettes rebuilt under R 4.6.1
  4. 1mo agomedsimseed= now honored in sequential fallback paths
  5. 2mo agomedsimDocs and dependency metadata synced to the 0.2.0 state
  6. 2mo agomedsimMissing-data mediation: amputation, non-normal DGMs, D4-MBCO
  7. 3mo agomedsimv0.1.1 — cleanup release
  8. 2y agoforecastingVignettes rebuilt under R 4.3.2
  9. 5y agoforecastingVignettes rebuilt under R 4.0.4
  10. 7y agoforecastingStandard PIT and discretized log-normal scoring
  11. 7y agoforecastingThe version used for the book chapter, with pinned dependencies

Frequently asked questions

What is the difference between forecasting and medsim?

Both compete on the same themes — reproducibility, r package — within Analytics. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is forecasting better than medsim?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to forecasting?

Top forecasting alternatives in Analytics are ranked by recent ship velocity. Browse the "forecasting alternatives" section above for the current picks, or visit /alternatives/forecasting for the full list with editorial commentary on each.

What are the best alternatives to medsim?

Top medsim alternatives in Analytics are ranked by recent ship velocity. Browse the "medsim alternatives" section above for the current picks, or visit /alternatives/medsim for the full list with editorial commentary on each.